Blood Oncology
Blood cancer means a huge group of incompatible malignancies. This group involves bone marrow cancers, blood cancers, and lymphatic system and lymphoid tissue cancers. Leukemia and myeloma refers to the bone marrow cancers, lymphoma refers to the lymphatic system. These are the most common types of blood cancer. Causes of these cancers are unknown. Leukemia and myeloma can interfere with the ability of bone marrow to generate blood cells, including WBC, RBC, and platelets. This can cause persistent infections and anemia. Enlargement of the lymph nodes are referred as lymphomas, can also fight against infections in the body. As well as, myelomas produce a substance which causes bones weakness, and generate abnormal proteins which can cause symptoms in other parts of the body. Treatment of blood cancers has undertaken considerable improvements. When there is no sign of cancer remission will occur. Today in the United States, Almost one million people in US are surviving with blood cancer. People with blood cancer can have complications with serious infections and bleeding. Most common cause of cancer is heavy use of Tobacco and it can cause 22% of cancer deaths. Lack of physical activity, poor diet, obesity these all are the factors of cancer.
- Carcinoma
- Sarcoma
- Mixed mesodermal tumour
Related Conference of Blood Oncology
Blood Oncology Conference Speakers
Recommended Sessions
- Blood Based Products
- Blood Disease Condition and Treatment
- Blood Oncology
- Blood Transplantation, Thrombosis and Hemostasis
- Case Reports and Epidemiology
- Diagnosis in Blood Disorder
- Hematologic Oncology
- Hematological Disorders
- Hematology and Pharma Industry
- Hematology and Stem Cell Research
- Hematology Market
- Hematology Nursing
- Immunology
- New Drug Development in Haematology
- New Drug Development in Hematology
- Pediatric Hematology
- Transfusion Medicine and Haematology Research
- Various Aspects of Hematology
Related Journals
Are you interested in
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)

